Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?

This publication has 41 references indexed in Scilit:

• The hibernating myocardium
  Published by Elsevier ,2004
• Improving patient outcomes in heart failure: evidence and barriers
  Heart, 2000
• Ten year survival after heart transplantation: palliative procedure or successful long term treatment?
  Heart, 1999
• The REMATCH trial: rationale, design, and end points
  The Annals of Thoracic Surgery, 1999
• Thallium scintigraphy compared with 18f-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction
  The American Journal of Cardiology, 1998
• Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.
  Circulation, 1994
• Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization.
  Circulation, 1994
• Stunning: Damaging or protective to the myocardium?
  Cardiovascular Drugs and Therapy, 1991
• An overview of contemporary etiologies of congestive heart failure
  American Heart Journal, 1991
• Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
  The American Journal of Cardiology, 1983